Ontolan, Esmeralda P.
HRN: 15-24-66 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/13/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/13/2025
12/20/2025
IV
500MG
Q8
PARTIAL MECHANICAL BOWEL OBSTRUCTION
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes